Acer Therapeutics (ACER)
(Delayed Data from OTC)
$0.66 USD
0.00 (0.00%)
Updated Nov 20, 2023 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Acer Therapeutics Inc. [ACER]
Reports for Purchase
Showing records 141 - 160 ( 213 total )
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
A Trio of Updates, with ACER-001 the Crown Jewel
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
Pipeline Event Offers Look Under the ACER Development Hood
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
As ACER Turns Page on Edsivo, Management Announces Restructuring
Provider: WEDBUSH SECURITIES INC.
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
EDSIVO Regulatory Roadblock; Pivoting to Pipeline; Reiterate Buy and Lowering Target to $10
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
FDA Puts the Brakes on Edsivo; Lowering Target to $8
Provider: WEDBUSH SECURITIES INC.
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
CRL Was a Total Surprise, but ACER Plans to Keep Trucking Along
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
After a Rough Month, Continue to Hold Positive Bias Into Key Catalyst
Provider: WEDBUSH SECURITIES INC.
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
Another Supportive vEDS Data Point Ahead of Key Catalyst
Provider: WEDBUSH SECURITIES INC.
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
EDSIVO Approval Decision Fast Approaching; 1Q 2019 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
Initiating at OUTPERFORM; Orphan Biotech Poised to Enter Commercial Markets
Provider: WEDBUSH SECURITIES INC.
Company: Acer Therapeutics Inc.
Industry: Medical - Drugs
Healthcare -Recap of 22 Expert Calls in 2018 - 2019 for Our Coverage Universe
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y